BioCryst Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US09058V1035

Introducere

Această pagină oferă o analiză cuprinzătoare a istoricului cunoscut al tranzacțiilor privilegiate a John L Higgins. Insiders sunt ofițeri, directori sau investitori importanți într-o companie. Este ilegal ca persoanele din interior să facă tranzacții în companiile lor pe baza unor informații specifice, nepublice. Acest lucru nu înseamnă că este ilegal pentru ei să facă tranzacții în propriile companii. Cu toate acestea, ei trebuie să raporteze toate tranzacțiile către SEC printr-un Formular 4. În ciuda acestor restricții, cercetările academice sugerează că persoanele din interior - în general - tind să depășească piața în propriile companii.

Rentabilitatea medie comercială

Rentabilitatea medie a comerțului este randamentul mediu al tuturor achizițiilor de pe piața deschisă efectuate de persoane din interior în ultimii trei ani. Pentru a calcula acest lucru, examinăm fiecare achiziție neplanificată pe piață deschisă făcută de către insider, excluzând toate tranzacțiile care au fost marcate ca parte a unui plan de tranzacționare 10b5-1. Apoi calculăm performanța medie a acelor tranzacții pe 3, 6 și 12 luni, făcând o medie a fiecărei durate pentru a genera o valoare finală a performanței pentru fiecare tranzacție. În cele din urmă, facem o medie a tuturor valorilor de performanță pentru a calcula o valoare de performanță pentru persoana din interior. Această listă include doar persoane din interior care au efectuat cel puțin trei tranzacții în ultimii doi ani.

Dacă profitabilitatea acestei tranzacții este „N/A”, atunci acesta fie nu a făcut nicio achiziție pe piața deschisă în ultimii trei ani, fie tranzacțiile pe care le-au făcut sunt prea recente pentru a calcula o măsură de performanță fiabilă.

Frecvența actualizării: zilnic

Consultați lista celor mai profitabili comercianți din interior.

Companii cu poziții din interior raportate

Înregistrările SEC indică faptul că John L Higgins a raportat participații sau tranzacții în următoarele companii:

Securitate Titlu Ultimele participații raportate
US:OABI / OmniAb, Inc. Director 2.942.320
US:TECH / Bio-Techne Corporation Director 66.876
US:LGND / Ligand Pharmaceuticals Incorporated Director 417.695
US:BCRX / BioCryst Pharmaceuticals, Inc. Director 15.000
Cum se interpretează diagramele

Următoarele diagrame arată performanța acțiunilor de valori mobiliare ulterioare fiecărei tranzacții neplanificate pe piață deschisă efectuată de John L Higgins. Comerțurile neplanificate sunt tranzacții care nu au fost efectuate ca parte a unui plan de tranzacționare 10b5-1. Performanța acțiunilor este reprezentată ca variație procentuală cumulată a prețului acțiunilor. De exemplu, dacă o tranzacție privilegiată a fost efectuată la 1 ianuarie 2019, graficul va afișa modificarea procentuală zilnică a titlului până în prezent. Dacă prețul acțiunilor ar merge de la 10 USD la 15 USD în acest timp, modificarea procentuală cumulativă a prețului acțiunilor ar fi de 50%. O modificare a prețului de la 10 USD la 20 USD ar fi 100%, iar o modificare a prețului de la 10 USD la 5 USD ar fi -50%.

În cele din urmă, încercăm să determinăm cât de strâns se corelează tranzacțiile insider-ului cu randamentele în exces (pozitive sau negative) ale prețului acțiunilor, pentru a vedea dacă insider-ul își programează tranzacțiile pentru a profita de informațiile privilegiate. Luați în considerare situația în care un insider făcea asta. În această situație, ne-am aștepta fie la (a) randamente pozitive după achiziții, fie (b) la profituri negative după vânzare. În cazul punctului (a), graficul CUMPĂRĂRI ar arăta o serie de curbe în pantă ascendentă, indicând randamente pozitive după fiecare tranzacție de cumpărare. În cazul (b), graficul VÂNZARE ar arăta o serie de curbe înclinate în jos, indicând randamente negative după fiecare tranzacție de vânzare.

Cu toate acestea, acest lucru în sine nu este suficient pentru a trage concluzii. Dacă, de exemplu, prețul acțiunilor companiei a fost într-o creștere neciclică de-a lungul multor ani, atunci ne-am aștepta ca toate parcelele post-cumpărare să fie în pantă ascendentă. De asemenea, scăderile non-ciclice de-a lungul multor ani ar avea ca rezultat o pantă descendentă post-tranzacționare. Niciunul dintre aceste grafice nu ar sugera activitate de tranzacționare a informațiilor privilegiate.

Cel mai puternic indicator ar fi o situație în care prețul acțiunilor a fost extrem de ciclic, și au existat atât semnale pozitive în graficul CUMPĂRARE, cât și grafice negative pe graficul VÂNZARE. Această situație ar sugera foarte mult un insider care a programat tranzacțiile în avantajul lor financiar.

Achiziții din interior BCRX / BioCryst Pharmaceuticals, Inc. - Analiza profitului pe termen scurt

În această secțiune, analizăm profitabilitatea fiecărei achiziții neplanificate, pe piață deschisă, efectuată în BCRX / BioCryst Pharmaceuticals, Inc.. Această analiză ajută la înțelegerea dacă persoana din interior generează în mod constant profituri anormale și merită urmărită. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel prezintă cele mai recente achiziții pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Max
Pret la
Max
Max
Profit ($)
Randament maxim (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

BCRX / BioCryst Pharmaceuticals, Inc. Insider Trades
Vânzări din interior BCRX / BioCryst Pharmaceuticals, Inc. - Analiza pierderilor pe termen scurt

În această secțiune, analizăm evitarea pierderilor pe termen scurt a fiecărei vânzări neplanificate, pe piață deschisă, efectuată în BCRX / BioCryst Pharmaceuticals, Inc.. Un model consistent de evitare a pierderilor poate sugera că viitoarele tranzacții de vânzare pot prezice scăderi ale prețului. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel arată cele mai recente vânzări pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Min
Pret la
Min
Pierdere maximă
Evitat ($)
Pierdere maximă
Evitat (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

BCRX / BioCryst Pharmaceuticals, Inc. Insider Trades
Istoricul tranzacțiilor privilegiate

Acest tabel arată lista completă a tranzacțiilor privilegiate efectuate de John L Higgins, astfel cum a fost dezvăluită Comisiei pentru Bursa de Valori Valori (SEC).

Data fișierului Tran Data Formă Ticker Securitate Cod 10b5-1 Acțiuni Acțiuni rămase La sută
Schimbare
Acțiune
Preț
Tran
Valoare
Rămas
Valoare
2026-01-30 2026-01-30 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 13.172 2.942.320 0,45
2025-11-10 2025-11-07 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 41.038 2.929.148 1,42 1,38 56.632 4.042.224
2025-11-10 2025-11-06 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 36.223 2.888.110 1,27 1,41 51.074 4.072.235
2025-11-03 2025-10-30 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 1.640 66.876 2,51
2025-08-11 2025-08-07 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 5.040 65.236 8,37 21,84 110.074 1.424.754
2025-06-18 2025-06-17 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 20.000 2.851.887 0,71
2025-05-13 2025-05-12 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 65.000 2.831.887 2,35 1,44 93.600 4.077.917
2025-05-05 2025-05-01 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 12.000 60.196 24,90 21,84 262.080 1.314.681
2025-03-21 2025-03-21 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 4.000 2.766.887 0,14 2,28 9.120 6.308.502
2025-03-20 2025-03-20 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 125.750 2.762.887 4,77 2,35 295.512 6.492.784
2025-01-30 2025-01-30 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 13.172 2.637.137 0,50
2024-10-28 2024-10-24 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 1.462 48.196 3,13
2024-09-16 2024-09-12 4 TECH BIO-TECHNE Corp
Common Stock
F - Taxes -1.874 46.734 -3,86 73,20 -137.177 3.420.929
2024-09-16 2024-09-12 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 6.000 48.608 14,08 22,95 137.700 1.115.554
2024-07-10 2024-07-08 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 6.000 42.608 16,39 22,95 137.700 977.854
2024-06-21 2024-06-18 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 20.000 2.623.965 0,77
2024-05-16 2024-05-14 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -4.000 36.608 -9,85 83,84 -335.377 3.069.372
2024-05-16 2024-05-14 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 4.000 40.608 10,93 22,95 91.800 931.954
2024-04-23 2022-11-01 4/A OABI OmniAb, Inc.
Common Stock
A - Award 2.427.861 2.603.965 1.378,65
2024-01-31 2024-01-30 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 13.173 2.352.625 0,56
2023-10-30 2023-10-26 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 1.625 36.608 4,65
2023-06-27 2023-01-04 4 OABI OmniAb, Inc.
Common Stock
F - Taxes 57.803 2.339.452 2,53 3,23 186.704 7.556.430
2023-06-27 2022-12-28 4 OABI OmniAb, Inc.
Common Stock
F - Taxes 25.914 2.397.255 1,09 3,66 94.845 8.773.953
2023-05-25 2023-05-23 4 OABI OmniAb, Inc.
Common Stock
S - Sale -9.000 2.462.686 -0,36 4,05 -36.450 9.973.878
2023-05-25 2023-05-23 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 9.000 2.471.686 0,37 3,68 33.120 9.095.804
2023-05-23 2023-05-19 4 OABI OmniAb, Inc.
Common Stock
S - Sale -1.000 2.462.686 -0,04 4,05 -4.050 9.973.878
2023-05-23 2023-05-19 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 1.000 2.463.686 0,04 3,68 3.680 9.066.364
2023-05-19 2023-05-18 4 OABI OmniAb, Inc.
Common Stock
S - Sale -50.000 2.462.686 -1,99 3,89 -194.500 9.579.849
2023-05-19 2023-05-18 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 50.000 2.512.686 2,03 3,68 184.000 9.246.684
2023-05-02 2023-04-28 4 TECH BIO-TECHNE Corp
Common Stock
F - Taxes -4.377 34.983 -11,12 79,88 -349.635 2.794.442
2023-05-02 2023-04-28 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 16.000 39.360 68,49 21,85 349.600 860.016
2023-02-01 2023-01-30 4 OABI OmniAb, Inc.
Common Stock
A - Award 39.517 2.462.686 1,63
2022-12-30 2022-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -5.289 417.695 -1,25 66,29 -350.608 27.689.002
2022-12-20 2022-12-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -10.000 422.984 -2,31 61,87 -618.657 26.168.201
2022-12-14 2022-12-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -3.944 432.984 -0,90 64,80 -255.571 28.057.363
2022-12-14 2022-12-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 20.000 436.928 4,80 12,78 255.600 5.583.940
2022-12-01 2022-11-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -9.803 416.928 -2,30 72,90 -714.639 30.394.051
2022-11-21 2022-11-18 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 426.731 2,40 12,78 127.800 5.453.622
2022-11-21 2022-11-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -10.000 416.731 -2,34 78,32 -783.173 32.637.247
2022-11-03 2022-11-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 45.922 424.731 12,12
2022-11-03 2022-11-02 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 246.648 2.423.169 11,33 2,52 621.553 6.106.386
2022-11-03 2022-11-01 4 OABI OmniAb, Inc.
Common Stock
A - Award 2.176.521 2.176.521
2022-10-31 2022-10-27 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 338 5.840 6,14
2022-09-22 2022-09-16 4/A LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -1.000 366.180 -0,27 88,06 -88.060 32.245.811
2022-09-16 2022-09-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3.000 364.180 -0,82 89,35 -268.050 32.539.483
2022-09-16 2022-09-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -2.000 367.180 -0,54 90,00 -180.000 33.046.200
2022-08-12 2022-08-11 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -8 5.502 -0,15 380,71 -3.046 2.094.666
2022-08-12 2022-08-11 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -504 5.510 -8,38 385,47 -194.277 2.123.936
2022-08-12 2022-08-10 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -992 6.014 -14,16 380,15 -377.112 2.286.240
2022-08-12 2022-08-10 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -100 7.006 -1,41 374,90 -37.490 2.626.514
2022-08-12 2022-08-10 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -900 7.106 -11,24 373,99 -336.593 2.657.586
2022-08-12 2022-08-10 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 3.400 8.006 73,82 66,90 227.460 535.601
2022-07-06 2022-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 164 369.180 0,04 75,84 12.437 27.997.504
2022-06-14 2022-06-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 20.423 369.016 5,86
2022-06-09 2022-06-08 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -600 4.606 -11,53 366,09 -219.654 1.686.211
2022-06-09 2022-06-08 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 600 5.206 13,03 66,90 40.140 348.281
2022-06-09 2022-06-07 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -1.000 4.606 -17,84 364,31 -364.310 1.678.012
2022-06-09 2022-06-07 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 1.000 5.606 21,71 66,90 66.900 375.041
2022-05-10 2022-05-10 4 LGND LIGAND PHARMACEUTICALS INC
0.75% Convertible Senior Notes due 2023
S - Sale 429.159,38
2022-05-10 2022-05-09 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -8.000 57.616 -12,19
2022-05-10 2022-05-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 8.000 348.593 2,35 21,92 175.360 7.641.159
2022-05-09 2022-05-05 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 76.478 76.478
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.916 340.593 -0,56 123,68 -236.971 42.124.542
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.061 342.509 -0,60 123,68 -254.904 42.361.513
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.946 344.570 -0,56 123,68 -240.681 42.616.418
2022-02-07 2021-11-15 5 LGND LIGAND PHARMACEUTICALS INC
Common Stock
G - Gift -2.502 332.593 -0,75
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -6.183 349.018 -1,74 113,68 -702.883 39.676.366
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3.060 355.201 -0,85 113,68 -347.861 40.379.250
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 13.560 358.261 3,93
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 9.606 344.701 2,87
2021-11-12 2021-11-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3.000 335.095 -0,89 160,50 -481.500 53.782.748
2021-11-01 2021-10-28 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
A - Award 633 633
2021-11-01 2021-10-28 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 194 4.606 4,40
2021-07-02 2021-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 247 338.095 0,07 85,91 21.220 29.045.572
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.061 337.848 -0,61 172,46 -355.440 58.265.266
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.947 339.909 -0,57 172,46 -335.780 58.620.706
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.204 341.856 -0,35 172,46 -207.642 58.956.486
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -54.666 14.334 -79,23
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -60.000 0 -100,00
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.970 343.060 -0,86 203,03 -602.999 69.651.472
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 60.000 346.030 20,98 10,05 603.000 3.477.602
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -54.666 286.030 -16,05 203,40 -11.119.239 58.179.417
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 54.666 340.696 19,11 14,47 791.017 4.929.871
2021-02-05 2021-02-03 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 25.113 25.113
2021-02-05 2021-02-03 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 12.608 286.030 4,61
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -30.000 65.616 -31,38
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -40.000 69.000 -36,70
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 30.000 273.422 12,32 21,92 657.600 5.993.410
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -40.000 243.422 -14,11 182,00 -7.280.000 44.302.804
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 40.000 283.422 16,43 14,47 578.800 4.101.116
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -50.000 109.000 -31,45
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -4.596 243.422 -1,85 156,01 -717.022 37.976.266
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 9.607 248.018 4,03
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.845 238.411 -1,18 156,01 -443.848 37.194.500
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5.946 241.256 2,53
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -50.000 235.310 -17,52 159,00 -7.950.000 37.414.290
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 50.000 285.310 21,25 14,47 723.500 4.128.436
2021-01-05 2020-12-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 223 235.310 0,09 84,53 18.851 19.891.343
2020-12-09 2020-12-08 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -14.657 60.000 -19,63
2020-12-09 2020-12-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.683 235.087 -0,71 87,52 -147.296 20.574.814
2020-12-09 2020-12-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 14.657 236.770 6,60 10,05 147.303 2.379.538
2020-11-10 2020-11-09 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -20.000 74.657 -21,13
2020-11-10 2020-11-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.458 222.113 -1,09 81,77 -200.991 18.162.180
2020-11-10 2020-11-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 20.000 224.571 9,78 10,05 201.000 2.256.939
2020-11-10 2020-11-06 4 TECH BIO-TECHNE Corp
Stock Option (Right to Buy)
M - Exercise -5.000 0 -100,00
2020-11-10 2020-11-06 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -3.100 4.412 -41,27 301,06 -933.301 1.328.297
2020-11-10 2020-11-06 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -450 7.512 -5,65 299,84 -134.928 2.252.392
2020-11-10 2020-11-06 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -1.450 7.962 -15,41 298,98 -433.516 2.380.451
2020-11-10 2020-11-06 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 5.000 9.412 113,33 70,35 351.750 662.134
2020-11-02 2020-10-29 4 TECH BIO-TECHNE Corp
Stock Option (Right to Buy)
A - Award 1.507 1.507
2020-11-02 2020-10-29 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 391 4.412 9,72
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.165 54.226 -2,10
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.373 93.627 -1,45
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.777 54.421 -3,16
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.373 204.571 0,68 74,42 102.179 15.224.174
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.777 203.198 0,88 56,26 99.974 11.431.919
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.165 201.421 0,58 85,79 99.945 17.279.908
2020-04-24 2019-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.310 133.982 -0,97 120,86 -158.327 16.193.065
2020-04-24 2019-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.689 135.292 -1,23 120,86 -204.133 16.351.391
2020-04-24 2019-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.918 136.981 -1,38 120,86 -231.809 16.555.524
2020-02-18 2020-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.117 205.173 -1,02 97,23 -205.836 19.948.971
2020-02-18 2020-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.310 207.290 -0,63 97,23 -127.371 20.154.807
2020-02-18 2020-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.689 208.600 -0,80 97,23 -164.221 20.282.178
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -48.125 0 -100,00
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 60.886 60.886
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 13.559 210.289 6,89
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -5.009 196.730 -2,48 95,68 -479.261 18.823.126
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 48.125 201.739 31,33 9,96 479.325 2.009.320
2020-02-14 2020-02-12 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
M - Exercise -5.000 0 -100,00
2020-02-14 2020-02-12 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -5.000 4.021 -55,43 205,23 -1.026.132 825.216
2020-02-14 2020-02-12 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 5.000 9.021 124,35 61,46 307.300 554.431
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.948 153.614 -1,88 105,87 -312.105 16.263.114
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5.946 156.562 3,95
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3.801 150.616 -2,46 105,87 -402.412 15.945.716
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7.668 154.417 5,23
2019-10-28 2019-10-24 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
A - Award 2.011 2.011
2019-10-28 2019-10-24 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 495 4.021 14,04
2019-09-24 2019-09-19 4/A LGND LIGAND PHARMACEUTICALS INC
0.75% Convertible Senior Notes due 2023
P - Purchase 988.468,75
2019-09-23 2019-09-19 4 LGND LIGAND PHARMACEUTICALS INC
0.75% Convertible Senior Notes due 2023
P - Purchase 841.250,00
2019-07-31 2019-07-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1.850 146.749 1,28 95,45 176.582 14.007.192
2019-06-06 2019-06-04 4 TECH BIO-TECHNE Corp
Stock Options (Right to buy)
M - Exercise -5.000 0 -100,00
2019-06-06 2019-06-04 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -5.000 3.526 -58,64 203,67 -1.018.346 718.137
2019-06-06 2019-06-04 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 5.000 8.526 141,80 63,03 315.150 537.394
2019-05-31 2019-05-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1.000 144.899 0,69 108,20 108.202 15.678.362
2019-05-14 2019-05-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 2.500 143.899 1,77 113,50 283.750 16.332.536
2019-03-15 2019-03-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 2.500 141.399 1,80 114,29 285.725 16.160.492
2019-02-13 2019-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 58.596 58.596
2019-02-13 2019-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 12.809 138.899 10,16
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3.168 126.090 -2,45 111,78 -354.119 14.094.340
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6.390 129.258 5,20
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3.597 122.868 -2,84 111,78 -402.073 13.734.185
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7.256 126.465 6,09
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4.000 0 -100,00
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -29.790 0 -100,00
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 29.790 119.209 33,32 16,14 480.811 1.924.033
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 4.000 89.419 4,68 16,14 64.560 1.443.223
2018-10-29 2018-10-25 4 TECH BIO-TECHNE Corp
Stock Options (Right to buy)
A - Award 1.898 1.898
2018-10-29 2018-10-25 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 514 3.526 17,07
2018-08-31 2018-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3.500 85.419 -3,94 258,25 -903.875 22.059.457
2018-08-27 2018-08-23 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
M - Exercise -10.000 0 -100,00
2018-08-27 2018-08-23 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -10.000 3.012 -76,85 187,92 -1.879.173 566.007
2018-08-27 2018-08-23 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 10.000 13.012 332,01 61,08 610.800 794.773
2018-08-17 2018-08-17 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -12.993 159.000 -7,55
2018-08-17 2018-08-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -12.993 88.919 -12,75 243,00 -3.157.299 21.607.317
2018-08-17 2018-08-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 12.993 101.912 14,61 14,47 188.009 1.474.667
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.007 171.993 -1,72
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -21.507 88.919 -19,48 241,33 -5.190.261 21.458.724
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 3.007 110.426 2,80 14,47 43.511 1.597.864
2018-05-15 2018-05-15 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -12.405 29.790 -29,40
2018-05-15 2018-05-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -12.405 107.419 -10,35 179,97 -2.232.491 19.331.875
2018-05-15 2018-05-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 12.405 119.824 11,55 16,14 200.217 1.933.959
2018-03-06 2018-03-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.982 107.419 -2,70 165,87 -494.624 17.817.590
2018-03-06 2018-03-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6.015 110.401 5,76
2018-03-06 2018-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 41.392 41.392
2018-03-06 2018-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7.928 104.386 8,22
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.689 96.458 -1,72 157,18 -265.477 15.161.268
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.918 98.147 -1,92 157,18 -301.471 15.426.745
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.635 100.065 -2,57 157,18 -414.169 15.728.217
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -9.000 102.700 -8,06 157,03 -1.413.279 16.127.084
2018-01-26 2018-01-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -22.500 111.700 -16,77 165,00 -3.712.500 18.430.500
2018-01-22 2018-01-19 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -16.249 42.195 -27,80
2018-01-22 2018-01-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -11.850 134.200 -8,11 151,92 -1.800.307 20.388.281
2018-01-22 2018-01-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -16.249 146.050 -10,01 155,00 -2.518.595 22.637.750
2018-01-22 2018-01-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 16.249 162.299 11,13 16,14 262.259 2.619.506
2017-12-29 2017-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -5.199 146.050 -3,44 138,66 -720.893 20.251.293
2017-12-29 2017-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 9.965 151.249 7,05
2017-11-20 2017-11-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -2.258 141.284 -1,57 140,34 -316.888 19.827.797
2017-11-17 2017-11-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -5.269 143.542 -3,54 142,53 -750.991 20.459.041
2017-10-30 2017-10-26 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
A - Award 3.125 3.125
2017-10-30 2017-10-26 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 739 3.012 32,51
2017-10-17 2017-10-13 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -11.384 0 -100,00
2017-10-17 2017-10-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.744 148.811 -1,16 143,04 -249.462 21.285.925
2017-10-17 2017-10-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 11.384 150.555 8,18 21,92 249.537 3.300.166
2017-09-06 2017-09-05 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -5.000 0 -100,00
2017-09-06 2017-09-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -5.000 139.171 -3,47 130,00 -650.000 18.092.230
2017-09-06 2017-09-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 5.000 144.171 3,59 21,00 105.000 3.027.591
2017-08-10 2017-08-08 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -5.483 5.000 -52,30
2017-08-10 2017-08-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -5.483 139.171 -3,79 125,00 -685.375 17.396.375
2017-08-10 2017-08-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 5.483 144.654 3,94 21,00 115.143 3.037.734
2017-06-23 2017-06-21 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -4.666 0 -100,00
2017-06-23 2017-06-21 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -4.666 139.171 -3,24 120,00 -559.920 16.700.520
2017-06-23 2017-06-21 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 4.666 143.837 3,35 21,00 97.986 3.020.577
2017-06-23 2008-02-23 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 4.666 4.666
2017-06-09 2017-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -12.000 10.483 -53,37
2017-06-09 2017-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -12.000 139.171 -7,94 114,87 -1.378.440 15.986.573
2017-06-09 2017-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 12.000 151.171 8,62 21,00 252.000 3.174.591
2017-03-21 2017-03-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -4.000 139.171 -2,79 109,10 -436.400 15.183.556
2017-03-10 2017-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -15.675 0 -100,00
2017-03-10 2017-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.473 143.171 -1,02 106,92 -157.493 15.307.843
2017-03-10 2017-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 15.675 144.644 12,15 10,05 157.534 1.453.672
2017-03-10 2017-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4.000 128.969 -3,01 107,06 -428.240 13.807.421
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 43.646 43.646
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 10.224 132.969 8,33
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -4.783 122.745 -3,75 100,38 -480.118 12.321.143
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 9.168 127.528 7,75
2017-02-28 2017-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.019 118.360 -1,68 104,28 -210.541 12.342.581
2017-02-28 2017-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.285 120.379 -1,86 104,28 -238.280 12.553.122
2016-10-31 2016-10-27 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
A - Award 3.985 3.985
2016-10-31 2016-10-27 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 914 2.273 67,26
2016-09-23 2016-09-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3.000 122.664 -2,39 117,34 -352.020 14.393.394
2016-09-12 2016-09-08 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -1.700 1.359 -55,57 109,83 -186.716 149.263
2016-03-09 2016-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -6.000 22.483 -21,07
2016-03-09 2016-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 6.000 125.664 5,01 21,00 126.000 2.638.944
2016-03-09 2016-03-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -556 119.664 -0,46 102,97 -57.251 12.321.802
2016-03-09 2016-03-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -10.277 120.220 -7,88 102,44 -1.052.776 12.315.337
2016-02-16 2016-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.492 130.497 -1,87 85,97 -214.237 11.218.827
2016-02-16 2016-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 55.391 55.391
2016-02-16 2016-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 11.611 132.989 9,57
2015-11-02 2015-10-29 4 TECH BIO-TECHNE Corp
Stock Option (Right to Buy)
A - Award 4.260 4.260
2015-11-02 2015-10-29 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 1.059 3.059 52,95
2015-08-07 2015-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4.666 121.378 -3,70 110,79 -516.946 13.447.469
2015-06-11 2015-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -500 126.044 -0,40 95,06 -47.530 11.981.743
2015-06-11 2015-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3.300 126.544 -2,54 93,21 -307.593 11.795.166
2015-06-11 2015-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -6.200 129.844 -4,56 92,53 -573.686 12.014.465
2015-02-11 2015-02-10 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 56.198 56.198 56,26 3.161.699 3.161.699
2015-02-11 2015-02-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 15.945 136.044 13,28
2014-11-03 2014-10-30 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
A - Award 4.000 4.000
2014-11-03 2014-10-30 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 1.000 2.000 100,00
2014-08-15 2014-08-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1.000 120.099 0,84 54,97 54.970 6.601.842
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -16.875 48.125 -25,96
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 10.000 95.000 11,76 74,42 744.200 7.069.900
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 10.000 95.000 11,76 74,42 744.200 7.069.900
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 75.000 75.000 74,42 5.581.500 5.581.500
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 8.000 119.099 7,20
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -16.875 111.099 -13,19 75,00 -1.265.625 8.332.425
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 16.875 127.974 15,19 9,96 168.075 1.274.621
2014-01-21 2014-01-21 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -9.000 28.483 -24,01 21,00 -189.000 598.143
2014-01-21 2014-01-21 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 9.000 111.099 8,81 21,00 189.000 2.333.079
2014-01-21 2014-01-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -15.000 102.099 -12,81 64,00 -960.000 6.534.336
2013-11-04 2013-10-31 4 TECH TECHNE CORP /MN/
Stock Option
A - Award 4.000 4.000
2013-11-04 2013-10-31 4 TECH TECHNE CORP /MN/
Common Stock
A - Award 1.000 1.000
2013-10-22 2013-10-22 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -5.850 37.483 -13,50
2013-10-22 2013-10-22 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -4.668 15.675 -22,95
2013-10-22 2013-10-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 4.668 117.099 4,15 10,05 46.913 1.176.845
2013-10-22 2013-10-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 5.850 112.431 5,49 21,00 122.850 2.361.051
2013-10-22 2013-10-18 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -10.000 106.581 -8,58 55,00 -550.000 5.861.955
2013-08-20 2013-08-19 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -6.556 58.444 -10,09
2013-08-20 2013-08-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 6.556 116.581 5,96 16,14 105.814 1.881.617
2013-08-20 2013-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -10.000 110.025 -8,33 42,85 -428.500 4.714.571
2013-06-04 2013-06-03 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 14.334 14.334 32,00 458.688 458.688
2013-06-04 2013-06-03 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 12.000 120.025 11,11
2013-06-04 2012-02-09 4/A LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 160.666 160.666 14,47 2.324.837 2.324.837
2013-06-04 2012-02-09 4/A LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6.000 95.275 6,72
2013-02-19 2013-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 95.616 95.616 21,92 2.095.903 2.095.903
2013-02-19 2013-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
A - Award 11.384 11.384 21,92 249.537 249.537
2013-02-19 2013-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 8.000 120.025 7,14
2012-12-05 2012-12-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 2.000 112.025 1,82 18,03 36.060 2.019.811
2012-10-26 2012-10-25 4 TECH TECHNE CORP /MN/
Stock Option
A - Award 5.000 5.000
2012-08-14 2012-08-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 500 110.025 0,46 16,39 8.195 1.803.310
2012-07-03 2012-06-29 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 1.250 109.525 1,15 10,12 12.654 1.108.776
2012-05-25 2012-05-23 4 BCRX BIOCRYST PHARMACEUTICALS INC
Automatic Stock Option Grant
A - Award 15.000 15.000
2012-05-08 2012-05-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1.000 108.275 0,93 12,04 12.040 1.303.631
2012-02-13 2012-02-09 4 LGNDD LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 175.000 175.000 14,47 2.532.250 2.532.250
2012-02-13 2012-02-09 4 LGNDD LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 18.000 107.275 20,16
2012-01-06 2011-12-30 4 LGNDD LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 210 89.275 0,24 10,09 2.119 900.740
2004-05-18 3/A BCRX BIOCRYST PHARMACEUTICALS INC
None
0
P
Piața deschisă sau achiziția privată de titluri nederivate sau derivate
S
Piața deschisă sau vânzarea privată a titlurilor de valoare nederivate sau derivate
A
Acordarea, atribuirea sau alte achiziții de valori mobiliare de la companie (cum ar fi o opțiune)
C
Conversia derivatei
D
Vânzarea sau transferul de valori mobiliare înapoi către companie
F
Plata prețului de exercițiu sau a obligației fiscale folosind o parte din titlurile de valoare primite de la companie
G
Donarea de valori mobiliare de către sau către persoane din interior
K
Swap-uri de acțiuni și tranzacții similare de acoperire împotriva riscurilor
M
Exercitarea sau conversia titlurilor derivate primite de la companie (cum ar fi o opțiune)
V
O tranzacție raportată voluntar pe Formularul 4
J
Altele (însoțite de o notă de subsol care descrie tranzacția)